| Literature DB >> 30528841 |
Cornelis Blauwendraat1, Olga Pletnikova2, Joshua T Geiger1, Natalie A Murphy3, Yevgeniya Abramzon4, Gay Rudow2, Adamantios Mamais3, Marya S Sabir1, Barbara Crain2, Sarah Ahmed3, Liana S Rosenthal5, Catherine C Bakker5, Faraz Faghri6, Ruth Chia3, Jinhui Ding3, Ted M Dawson7, Alexander Pantelyat5, Marilyn S Albert5, Mike A Nalls8, Susan M Resnick9, Luigi Ferrucci10, Mark R Cookson3, Argye E Hillis5, Juan C Troncoso11, Sonja W Scholz12.
Abstract
Molecular genetic research provides unprecedented opportunities to examine genotype-phenotype correlations underlying complex syndromes. To investigate pathogenic mutations and genotype-phenotype relationships in diverse neurodegenerative conditions, we performed a rare variant analysis of damaging mutations in autopsy-confirmed neurodegenerative cases from the Johns Hopkins Brain Resource Center (n = 1243 patients). We used NeuroChip genotyping and C9orf72 hexanucleotide repeat analysis to rapidly screen our cohort for disease-causing mutations. In total, we identified 42 individuals who carried a pathogenic mutation in LRRK2, GBA, APP, PSEN1, MAPT, GRN, C9orf72, SETX, SPAST, or CSF1R, and we provide a comprehensive description of the diverse clinicopathological features of these well-characterized cases. Our study highlights the utility of high-throughput genetic screening arrays to establish a molecular diagnosis in individuals with complex neurodegenerative syndromes, to broaden disease phenotypes and to provide insights into unexpected disease associations. Published by Elsevier Inc.Entities:
Keywords: Brain bank; Genotype-phenotype; NeuroChip; Neurodegeneration
Mesh:
Substances:
Year: 2018 PMID: 30528841 PMCID: PMC6391207 DOI: 10.1016/j.neurobiolaging.2018.11.007
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673